The price of PROK is predicted to go up 6.67%, based on the high correlation periods with LINK. The similarity of these two price pattern on the periods is 90.9%.
PROK
LINK
Up: 6.67%Similarity: 90.9%
PROK Revenue Forecast
PROK EPS Forecast
PROK FAQs
What is bull’s view on PROK?
JP Morgan projects a 155.92% upside for PROK, with a one-year price target of $4.76 from its current $1.86, driven by institutional ownership growth and bullish sentiment. Guggenheim also initiated a "Buy" rating with a $6 target, citing renewed leadership and potential. The low put/call ratio (0.22) further supports a bullish outlook.
What is bear's view on PROK?
ProKidney (PROK) is currently trading at $1.86, with JP Morgan projecting a neutral stance but a potential upside to $4.76 (155.92%). Despite negative EPS (-$0.71) and no revenue, increased institutional ownership and a low put/call ratio (0.22) suggest bullish sentiment. However, the stock remains speculative due to its financials and reliance on future growth.
What is PROK eps forecast for next quarter?
The market consensus for PROK's eps in the upcoming quarter is projected to be approximately $0.51 USD.